To recover your password please fill in your email address
Please fill in below form to create an account with us
The T4DM study aims to determine whether testosterone treatment combined with a lifestyle intervention (Weight Watchers®), compared to lifestyle intervention alone, reduces the incidence of Type 2 Diabetes in high-risk, overweight and obese adults aged 50 - 74 years.
See ANZCTR for full trial details >
T4DM Participant Information and study outcomes >
|
Trial Summary: |
T4DM is a large, multi-centre, phase III, double-blind, placebo-controlled two-year trial of testosterone therapy combined with a lifestyle intervention (Weight Watchers®) compared to the lifestyle intervention alone for the prevention of Type 2 diabetes. The trial is run through six centres in Australian capital cities. Recruitment to the study closed in February 2017 with 1007 participants enrolled. The trial is ongoing and follow-up is due to be completed in May 2019. |
|
Supported By: |
NHMRC Project Grant 1030123, Bayer, Lilly, University of Adelaide. Weight Watchers® provided enrolment to their program for trial participants without cost. |
|
Eligibility: |
Adults aged 50 -74 years, overweight or obese, pre-diabetic or newly diagnosed diabetic and with testosterone ≤14nmol/L. |
|
Registration ID: |
ACTRN12612000287831 |
|
Participation: |
1,007 adults were enrolled in the study |
|
Australian Lead Group: |
NHMRC CTC |
|
Status: |
Closed |
|
Activation Date: |
25/10/2018 |
|
Chairs: |
Prof Gary Wittert |
|
Contact: |